Works matching IS 17597706 AND DT 2023 AND VI 14 AND IP 11
Results: 10
Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta‐analysis of randomized controlled trials.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 1029, doi. 10.1111/1759-7714.14842
- By:
- Publication type:
- Article
Segmentectomy versus lobectomy for small‐sized pure solid non–small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 1021, doi. 10.1111/1759-7714.14840
- By:
- Publication type:
- Article
Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR‐TKI in non–small cell lung cancer patients with EGFR mutation: A multicenter retrospective study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 1004, doi. 10.1111/1759-7714.14836
- By:
- Publication type:
- Article
Epigenetic and genetic inactivation of tumor suppressor miR‐135a in non‐small‐cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 1012, doi. 10.1111/1759-7714.14838
- By:
- Publication type:
- Article
Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 992, doi. 10.1111/1759-7714.14835
- By:
- Publication type:
- Article
Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small‐cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 1036, doi. 10.1111/1759-7714.14832
- By:
- Publication type:
- Article
Carboxypeptidase vitellogenic like facilitates resistance to CDK4/6 inhibitors in breast cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 983, doi. 10.1111/1759-7714.14829
- By:
- Publication type:
- Article
Good practice: The experiences with the utilization of residual cancer burden—A single institution study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 963, doi. 10.1111/1759-7714.14826
- By:
- Publication type:
- Article
SPATA2 suppresses epithelial‐mesenchymal transition to inhibit metastasis and radiotherapy sensitivity in non–small cell lung cancer via impairing DVL1/β‐catenin signaling.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 969, doi. 10.1111/1759-7714.14828
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 11, p. 961, doi. 10.1111/1759-7714.14497
- Publication type:
- Article